US FDA prepares for outside scrutiny of medtech review processes
This article was originally published in Clinica
Executive Summary
The US FDA is inviting feedback from the medtech industry on its plans to hire a private, independent consultancy organisation to assess its pre-market processes for reviewing medical devices.